UNSPSC 51282919: Flumequine

This classification denotes a quinolone antibiotic with the molecular formula C14H12FNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UVG8VSP2SJ, chemically known as 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1h,5h-quinolizine-2-carboxylic acid but generally known as flumequine, which bears US NIH Compound Identifier 3374. European Medicines Agency schedules Flumequine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07696MIG.

UNSPSC 51282919 Flumequine is a Commodity code for a specific veterinary and aquacultural fluoroquinolone antibiotic, but recent state and local procurement activity under this code shows minimal relevant purchasing. The two most recent opportunities posted under the code—one from Illinois Department of Public Health and one from Seminole County, Florida—do not involve flumequine. Illinois procured Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through a piggyback pharmaceutical warehouse contract awarded to Chartwell Rx LLC in August 2026, while Seminole County sought Naloxone and drug deactivation systems for community health use. Neither solicitation aligns with flumequine's therapeutic scope, suggesting either sparse state and local demand for the product or systematic mistagging in the opportunities database.

State and local procurement activity under this Commodity code does not currently support business development focus. The few available records show purchasing by a state health department and a county government, but neither transaction involves the stated UNSPSC product. Flumequine remains a niche pharmaceutical with limited civilian health-system use in the United States, and state and local procurement records offer no visibility into active demand or pipeline opportunities for the product itself.